cromakalim has been researched along with thiopental in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishida, K; Ishikawa, T; Kinoshita, H | 1 |
| Ding, X; Murray, PA; Roh, WS | 1 |
2 other study(ies) available for cromakalim and thiopental
| Article | Year |
|---|---|
Thiopental and propofol impair relaxation produced by ATP-sensitive potassium channel openers in the rat aorta.
Topics: Adenosine Triphosphate; Anesthetics, Intravenous; Animals; Aorta, Thoracic; Cromakalim; Dose-Response Relationship, Drug; Male; Pinacidil; Potassium Channels; Propofol; Rats; Rats, Inbred WKY; Thiopental; Vasodilation; Vasodilator Agents | 1998 |
Propofol and thiopental attenuate adenosine triphosphate-sensitive potassium channel relaxation in pulmonary veins.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Triphosphate; Anesthetics, Intravenous; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Cromakalim; Cyclooxygenase Inhibitors; Dogs; Drug Administration Schedule; Endothelium, Vascular; Enzyme Inhibitors; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Nitric Oxide Synthase; Potassium Channels; Propofol; Pulmonary Veins; Thiopental; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2006 |